Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
**Background:** Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are risk factors for venous thromboembolism (VTE). Enoxaparin and unfractionated heparin (UFH) help prevent hospital-associated VTE, but few studies have compared them in COPD or HF. **Objectives:** To compare effec...
Saved in:
Main Authors: | Alpesh N. Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.92408 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight-based enoxaparin thromboprophylaxis in young trauma patients: analysis of the CLOTT-1 registry
by: Sarah Lombardo, et al.
Published: (2024-07-01) -
Inhibition of Gastric Acid Secretion by Unfractionated and Low Molecular Weight Heparins in the Rat
by: Omar M.E. Abdel Salam, et al.
Published: (2006-01-01) -
Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
by: Tung Phi Nguyen, et al.
Published: (2021-01-01) -
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin—A Randomized, Controlled, Crossover Study
by: Liva K. Stuhr, et al.
Published: (2025-01-01) -
Thromboprophylaxis in multiple myeloma
by: Laurent Frenzel
Published: (2025-01-01)